quinta-feira, 8 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 17, 2026

How Much the Top 5% Pay in Taxes in Every State

View original at finance.yahoo.com
How Much the Top 5% Pay in Taxes in Every State The percentage of income America’s top earners get to keep varies dramatically depending on which state they call home…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The combined weight of federal, state and FICA taxes can consume nearly half of a paycheck in some areas while leaving significantly more on the table in others.

    80% confidence
  • South Dakota provides the most tax-friendly environment for the top 5%, with burdens of only 31.3% (single) and 23.6% (married).

    80% confidence
  • Across all states, the average tax burden for a single filer is approximately 36.1%, while the burden for a married couple is 28.8%, representing a savings of over 7% of total income.

    80% confidence
  • There are nine states with no state income tax: Alaska, Florida, Nevada, New Hampshire, South Dakota, Tennessee, Texas, Washington and Wyoming.

    80% confidence
  • In states with no state income tax, the total tax burden for the top 5% is driven almost entirely by federal and FICA taxes, consistently keeping their total burden below the national average.

    80% confidence
  • Connecticut has the highest average top 5% income at $691,840, while Mississippi has the lowest at $350,029, a difference of over $300,000.

    80% confidence
  • High earners in California face the nation's heaviest tax burden, losing 42.8% of their income if filing single and 35.8% if married.

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
How Much the Top 5% Pay in Taxes in Every State — Source | Via News | pt.VIA.NEWS